These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 19153505

  • 1. Use of recombinant human growth hormone in children with thalassemia.
    Geffner ME, Karlsson H.
    Horm Res; 2009 Jan; 71 Suppl 1():46-50. PubMed ID: 19153505
    [Abstract] [Full Text] [Related]

  • 2. Final height in Swedish children with idiopathic growth hormone deficiency enrolled in KIGS treated optimally with growth hormone.
    Westphal O, Lindberg A, Swedish KIGS National Board.
    Acta Paediatr; 2008 Dec; 97(12):1698-706. PubMed ID: 18976357
    [Abstract] [Full Text] [Related]

  • 3. Short-term therapy with recombinant growth hormone in polytransfused thalassaemia major patients with growth deficiency.
    Cavallo L, Gurrado R, Zecchino C, Manolo F, De Sanctis V, Cisternino M, Caruso-Nicoletti M, Galati M.
    J Pediatr Endocrinol Metab; 1998 Dec; 11 Suppl 3():845-9. PubMed ID: 10091155
    [Abstract] [Full Text] [Related]

  • 4. Insulin-like growth factor I and growth responses during the first year of growth hormone treatment in KIGS patients with idiopathic growth hormone deficiency, acquired growth hormone deficiency, turner syndrome and born small for gestational age.
    Cutfield WS, Lundgren F.
    Horm Res; 2009 Jan; 71 Suppl 1():39-45. PubMed ID: 19153504
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [The model of height prognosis in children with growth hormone deficiency].
    Kostecka L, Wasikowa R, Noczyńska A, Filipowski H.
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004 Jan; 10(2):113-7. PubMed ID: 15504314
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Growth hormone (GH) deficiency in patients with beta-thalassemia major and the efficacy of recombinant GH treatment.
    Wu KH, Tsai FJ, Peng CT.
    Ann Hematol; 2003 Oct; 82(10):637-40. PubMed ID: 12898188
    [Abstract] [Full Text] [Related]

  • 9. Growth in pre-pubertal children with myelomeningocele (MMC) on growth hormone (GH): the KIGS experience.
    Trollmann R, Bakker B, Lundberg M, Doerr HG.
    Pediatr Rehabil; 2006 Oct; 9(2):144-8. PubMed ID: 16449073
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Growth hormone treatment for short stature in children born small for gestational age.
    Jung H, Rosilio M, Blum WF, Drop SL.
    Adv Ther; 2008 Oct; 25(10):951-78. PubMed ID: 18836868
    [Abstract] [Full Text] [Related]

  • 12. Growth hormone treatment in prepubertal children with celiac disease and growth hormone deficiency.
    Giovenale D, Meazza C, Cardinale GM, Farinelli E, Mastrangelo C, Messini B, Citro G, Del Vecchio M, Di Maio S, Possenti I, Bozzola M.
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):433-7. PubMed ID: 18030209
    [Abstract] [Full Text] [Related]

  • 13. Growth hormone responsiveness: peak stimulated growth hormone levels and other variables in idiopathic short stature (ISS): data from the National Cooperative Growth Study.
    Moore WV, Dana K, Frane J, Lippe B.
    Pediatr Endocrinol Rev; 2008 Sep; 6(1):5-8. PubMed ID: 18806719
    [Abstract] [Full Text] [Related]

  • 14. Long-term recombinant human growth hormone use in Australian children with renal disease.
    Crompton CH, Australian and New Zealand Paediatric Nephrology Association.
    Nephrology (Carlton); 2004 Oct; 9(5):325-30. PubMed ID: 15504147
    [Abstract] [Full Text] [Related]

  • 15. The -202 A allele of insulin-like growth factor binding protein-3 (IGFBP3) promoter polymorphism is associated with higher IGFBP-3 serum levels and better growth response to growth hormone treatment in patients with severe growth hormone deficiency.
    Costalonga EF, Antonini SR, Guerra-Junior G, Mendonca BB, Arnhold IJ, Jorge AA.
    J Clin Endocrinol Metab; 2009 Feb; 94(2):588-95. PubMed ID: 18984657
    [Abstract] [Full Text] [Related]

  • 16. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
    Ranke MB, Lindberg A, Price DA, Darendeliler F, Albertsson-Wikland K, Wilton P, Reiter EO, KIGS International Board.
    Horm Res; 2007 Feb; 68(2):53-62. PubMed ID: 17228181
    [Abstract] [Full Text] [Related]

  • 17. [Evaluation of final height in patients with pituitary growth hormone deficiency who were treated with growth hormone replacement].
    Korpal-Szczyrska M, Dorant B, Kamińska H, Birkholz D, Niedźwiecki M.
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006 Feb; 12(1):31-4. PubMed ID: 16704859
    [Abstract] [Full Text] [Related]

  • 18. Use of growth hormone in children.
    Hindmarsh PC, Dattani MT.
    Nat Clin Pract Endocrinol Metab; 2006 May; 2(5):260-8. PubMed ID: 16932297
    [Abstract] [Full Text] [Related]

  • 19. Near adult heights after growth hormone treatment in patients with idiopathic short stature or idiopathic growth hormone deficiency.
    Frindik JP, Kemp SF, Hunold JJ.
    J Pediatr Endocrinol Metab; 2003 May; 16 Suppl 3():607-12. PubMed ID: 12795361
    [Abstract] [Full Text] [Related]

  • 20. Alterations in the oxidant-antioxidant status in prepubertal children with growth hormone deficiency: effect of growth hormone replacement therapy.
    Mohn A, Marzio D, Giannini C, Capanna R, Marcovecchio M, Chiarelli F.
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):537-42. PubMed ID: 16268806
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.